Atazanavir--first protease inhibitor for one dose administration
Bierl, H.
Deutsche Medizinische Wochenschrift 128(39): 2039-2040
2003
ISSN/ISBN: 0012-0472 PMID: 14565208 Document Number: 557885
Document emailed within 1 workday
Related Documents
Piliero, P.J. 2004: Atazanavir: A novel once-daily protease inhibitor Drugs of Today 40(11): 901-912Manosuthi, W.; Sungkanuparph, S.; Ruxrungtham, K.; Prasithsirikul, W.; Athichathanabadi, C.; Tantisiriwat, W.; Bowonwatanuwong, C.; Chumpathat, N.; Chaovavanich, A. 2008: Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir Journal of Acquired Immune Deficiency Syndromes 47(1): 127-129
Gaillard, M.C.; Reichberg, S.B.; Nogueira, C.M.; Kilroe-Smith, T.A. 1993: Differences in elastase-binding activity of alpha 1-protease inhibitor and alpha 2-macroglobulin for asthma patients and control subjects with various alpha 1-protease inhibitor phenotypes Clinical Chemistry 39(4): 675-679
Wakayama, T.; Itoh, T.; Shibayama, K.; Idezuki, Y. 1989: Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs American Journal of Gastroenterology 84(3): 272-278
Ohkoshi, M.; Fujii, S. 1982: Effect of oral administration of protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of 3-methylcholanthrene-induced carcinoma in mice Gan 73(1): 108-110
Traber, D.L.; Adams, T.; Sziebert, L.; Williams, P.; Traber, L.D. 1984: Failure of a protease inhibitor to affect the cardiopulmonary response to endotoxin when combined with a cyclooxygenase inhibitor Circulatory Shock 13(4): 319-323
Theron, A.J.; Anderson, R. 1988: Investigation of the effects of oral administration of ascorbate on the functional activity of serum alpha-1-protease inhibitor and oxidant release by blood phagocytes from cigarette smokers in a placebo-controlled, doubleblind, crossover trial International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 58(2): 218-224
Della Porta, P.; Soeltl, R.; Krell, H.W.; Collins, K.; O'Donoghue, M.; Schmitt, M.; Krüger, A. 1999: Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo Anticancer Research 19(5b): 3809-3816
Patel, A.K.; Patel, K.K.; Naik, E.; Jingyi Duan; Ranjan, R.; Patel, J.K.; Salihu, H.M. 2011: Comparison of the Effectiveness of Low-Dose Indinavir/Ritonavir (IDV/r)- versus Atazanavir/Ritonavir (ATV/r)-Based Generic Antiretroviral Therapy in NNRTI-Experienced HIV-1-Infected Patients in India Journal of the International Association of Physicians in Aids Care 10(2): 111-118
Besson, C.; Jubault, V.; Viard, J.P.; Pialoux, G. 1998: Ketoacidosis associated with protease inhibitor therapy Aids 12(11): 1399-1400
Race, E. 2001: Cross-resistance within the protease inhibitor class Antiviral Therapy 6(Suppl 2): 29-36
Gastaldi, G.; Mattiello, A. 1971: Effect of a protease inhibitor on bacterial multiplication Pathologica 63(923): 223-231
Buch, H.J. 1970: Treatment of arthrosis with protease-inhibitor Contrykal Das Deutsche Gesundheitswesen 25(20): 947-950
Cabot de Vega, E.; Fontecha Gómez, B.J.; Solé Arnau, R.; Pedrol Clotet, E. 1999: Peripheral lipodystrophy associated with protease inhibitor therapy Revista Clinica Espanola 199(8): 546-547
Juhász, S. 1983: Studies on the protease inhibitor of Klebsiella aerogenes Acta Veterinaria Hungarica 31(4): 121-123
Viciana, P.; Miralles-Martín, P.; Knobel, H.; Gatell, J.M. 1998: Prevention of opportunistic infections in the protease inhibitor era Enfermedades Infecciosas y Microbiologia Clinica 16 Suppl. 1: 1-10
Eftekhari, N.; Ward, A.M.; Allen, R.; Greaves, M.W. 1980: Protease inhibitor profiles in urticaria and angio-oedema British Journal of Dermatology 103(1): 33-39
Ala, P.J.; Rodgers, J.D.; Chang, C.H. 1999: HIV protease drug resistance and its impact on inhibitor design Current Opinion in Drug Discovery and Development 2(4): 265-273
Rattanasupar, A.; Sengmanee, S. 2016: Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding Journal of the Medical Association of Thailand 99(9): 988-995
Ameshima, S.; Ishizaki, T. 1999: Granulocyte elastase-alpha 1 protease inhibitor complex (GEPIC) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 813-815